
WINDWARD BIO GROUP AG
Nasdaq · Biological Products, (No Diagnostic Substances)
Company Overview
A concise company profile alongside the latest public filing activity.
Windward Bio AG is a clinical-stage biopharmaceutical company based in Basel, Switzerland, developing biologic therapies for inflammatory and immune-related diseases.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| ORBIMED ADVISORS LLCDirector | Buy | $20.00M | 1,176,471at $17.00 | Nov 16, 2026 |
| Stampacchia OtelloDirector | Buy | $14.88M | 875,000at $17.00 | Nov 16, 2026 |
| Bonita David PDirector | Buy | $20.00M | 1,176,471at $17.00 | Nov 16, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable WWB activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.